| 2014-01 |
Androgen receptor, ccl2, and epithelial-mesenchymal transition: A dangerous affair in the tumor microenvironment |
OncoImmunology. 2014 Jan;3(2):Article number e27871. |
 |
| 2013-11 |
Androgen receptor-mediated apoptosis in bovine testicular induced pluripotent stem cells in response to phthalate esters |
Cell Death and Disease. 2013 Nov;4(11):Article number e907. |
|
| 2011-11 |
Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc |
Cancer Science. 2011 Nov;102(11):2022-2028. |
|
| 2014-10-01 |
Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2 |
PLoS ONE. 2014 Oct 1;9(10):Article number 0109170. |
|
| 2014-10 |
Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2[Erratum: PLoS ONE. 2014 Oct 1;9(10):Article number 0109170] |
PLoS ONE. 2014 Oct;9(10):Article number e111731. |
|
| 2013-12-30 |
Androgenic alopecia is associated with less dietary soy, higher blood vanadium and rs1160312 1 polymorphism in Taiwanese communities |
PLoS ONE. 2013 Dec 30;8(12):Article number e79789. |
|
| 2011-08 |
Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer |
Journal of Biomedical Science. 2011 Aug;18(1):Article number 63. |
|
| 2013-07 |
Andrographis paniculata extract and andrographolide modulate the hepatic drug metabolism system and plasma tolbutamide concentrations in rats |
Evidence-Based Complementary and Alternative Medicine. 2013 Jul;2013:Article number 982689. |
|
| 2024-09 |
Andrographolide suppresses the malignancy of pancreatic cancer via alleviating DNMT3B-dependent repression of tumor suppressor gene ZNF382 |
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 2024 Sep;132:Article number 155860. |
|
| 2017-05-05 |
Anemia risk in relation to lead exposure in lead-related manufacturing |
BMC Public Health. 2017 May 5;17:Article number 389. |
|
| 2009-05 |
Anemia-related hemogram, uterine artery pulsatility index, and blood pressure for the effects of Four-Agents-Decoction (Si Wu Tang) in the treatment of primary dysmenorrhea |
Journal of Alternative and Complementary Medicine. 2009 May;15(5):531-538. |
|
| 2023-08 |
Anesthetic modulation of water diffusion: Insights from a diffusion tensor imaging study |
Medical Engineering and Physics. 2023 Aug;118:Article number 104015. |
|
| 2022-02-11 |
Angiogenesis driven by the CEBPD–hsa-miR-429–VEGFA signaling axis promotes urothelial carcinoma progression |
Cells. 2022 Feb 11;11(4):Article number 638. |
|
| 2006-05 |
Angiogenic and morphological response of locally advanced breast cancer to neoadjuvant chemotherapy: Color Doppler ultrasound evaluation |
Ultrasound in Medicine and Biology. 2006 May;32(5, Suppl):p163. |
|
| 2008-07 |
Angiogenic evaluation of ginsenoside Rg(1) from Panax ginseng in fluorescent transgenic mice |
Vascular Pharmacology. 2008 Jul;49(1):37-43. |
|
| 2013-02 |
Angiomatoid fibrous histiocytoma: Clincopathological and molecular characterization with emphasis on variant histomorphology |
Laboratory Investigation. 2013 Feb;93(Suppl. 1):14A. |
|
| 2013-02 |
Angiomatoid fibrous histiocytoma: Clincopathological and molecular characterization with emphasis on variant histomorphology |
Modern Pathology. 2013 Feb;26(Suppl. 2):14A. |
|
| 2015-08-14 |
Angiopoietin-2 as a prognostic biomarker of major adverse cardiovascular events and all-cause mortality in chronic kidney disease |
PLoS ONE. 2015 Aug 14;10(8):Article number e0135181. |
|
| 2016-12-19 |
Angiopoietin-2, angiopoietin-1 and subclinical cardiovascular disease in chronic kidney disease |
Scientific Reports. 2016 Dec 19;6:Article number 39400. |
|
| 2016-11 |
Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma |
Hepatology. 2016Nov;64(5):1637-1651. |
|
| 2022-04-20 |
Angiotensin II receptor blocker associated with less outcome risk in patients with acute kidney disease |
Frontiers in Pharmacology. 2022 Apr 20;13:Article number 714658. |
|
| 2015-10 |
Angiotensin IV possibly acts through PKMzeta in the hippocampus to regulate cognitive memory in rats |
Neuropeptides. 2015 Oct;53:1-10. |
|
| 2017-12-07 |
Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade |
PLoS ONE. 2017 Dec 7;12(12):Article number e0189126. |
|
| 2014-10-01 |
Angiotensin-converting enzyme inhibitor or Angiotensin receptor blocker use and renal outcomes-reply |
JAMA Internal Medicine. 2014 Oct 1;174(10):1706-1707. |
|
| 2016-03 |
Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and the risk of major adverse cardiac events in patients with diabetes and prior stroke: A nationwide study |
Journal of Hypertension. 2016 Mar;34(3):567-575. |
|
